Publication | Closed Access

Application of LC-NMR and LC-MS to the identification of degradation products of a protease inhibitor in dosage formulations

Protease InhibitorBiochemistryMedicineDrug DiscoveryBioanalysisMass SpectrometryPharmacologyNatural SciencesDegradation ProductsAnalytical ChemistryDosage FormulationsLiquid ChromatographyClinical ChemistryDrug DevelopmentProteomicsChromatographyDrug Analysis